Adjuva Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Adjuva Bio General Information
Description
Developer of a cell therapy platform designed to address chronic inflammatory and fibrotic conditions. The company offers in vivo cell therapies, programmable cellular treatments, and messenger ribonucleic acid-based therapeutics, enabling the development of targeted treatments for inflammatory diseases, fibrotic disorders, and endometriosis through precision-engineered cellular programming.
Contact Information
Corporate Office
- Oakland, CA
- United States
Corporate Office
- Oakland, CA
- United States
Adjuva Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 29-Apr-2025 | Completed | Startup |
Adjuva Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Charles River Incubator Program | Accelerator/Incubator |
Adjuva Bio FAQs
-
When was Adjuva Bio founded?
Adjuva Bio was founded in 2024.
-
Where is Adjuva Bio headquartered?
Adjuva Bio is headquartered in Oakland, CA.
-
What industry is Adjuva Bio in?
Adjuva Bio’s primary industry is Drug Discovery.
-
Is Adjuva Bio a private or public company?
Adjuva Bio is a Private company.
-
What is Adjuva Bio’s current revenue?
The current revenue for Adjuva Bio is .
-
Who are Adjuva Bio’s investors?
Charles River Incubator Program has invested in Adjuva Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process